Cambridge Investment Research Advisors, Inc. Standard Biotools Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.6 Billion
Q1 2025

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$4.35 - $6.35 $237,083 - $346,087	-54,502 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$3.94 - $7.09 $7,084 - $12,747	-1,798 Reduced 3.19%	54,502 $246,000
Q4 2020 Feb 04, 2021	BUY	$5.45 - $8.65 $129,165 - $205,005	23,700 Added 72.7%	56,300 $337,000
Q3 2020 Oct 29, 2020	BUY	$4.34 - $11.43 $69,874 - $184,023	16,100 Added 97.58%	32,600 $242,000
Q2 2020 Jul 27, 2020	BUY	$1.85 - $5.29 $30,525 - $87,285	16,500 New	16,500 $66,000
Q4 2019 Feb 04, 2020	SELL	$2.3 - $5.12 $28,749 - $64,000	-12,500 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$11.49 - $14.17 $143,625 - $177,125	12,500 New	12,500 $0

Others Institutions Holding LAB

# of Institutions

144

Shares Held

273M

Call Options Held

6.7K

Put Options Held

48.7K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $91.2M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account